NCT03649074View on ClinicalTrials.gov

Software Treatment for Actively Reducing Severity of ADHD as Adjunctive Treatment to Stimulant

NACompletedINTERVENTIONAL

Enrollment

206

Participants

Timeline

Start Date

December 28, 2018

Primary Completion Date

September 23, 2019

Study Completion Date

September 23, 2019

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DEVICE

AKL-T01

"AKL-T01 multitasking digital treatment. AKL-T01 multitasking treatment employs perceptual discrimination attention/memory task as well as a continuous motor driving task."

Trial Locations (2)

85254

Melmed Center, Scottsdale

89128

Center for Psychiatry and Behavioral Medicine, Las Vegas

All Listed Sponsors

lead

Akili Interactive Labs, Inc.

INDUSTRY

NCT03649074 - Software Treatment for Actively Reducing Severity of ADHD as Adjunctive Treatment to Stimulant | Biotech Hunter | Biotech Hunter